SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (1200)9/24/1998 6:15:00 PM
From: Ed Ajootian  Read Replies (2) | Respond to of 10280
 
Noticed that Soros filed another Form 13D re: his SEPR position with the SEC on 9/4. Does anyone know what the jist of this filing was? IE, did he & his affiliates go up or down, and by how many shares.

As long as Gorgeous George is hanging in there this kid's gonna too!



To: John Metcalf who wrote (1200)9/25/1998 7:51:00 PM
From: A.J. Mullen  Respond to of 10280
 
Billy & John

Stock splitting always seems a diversion to me. Until the cost of a single share is a substantial fraction of the value of the trade anyone is likely to make, who cares? If you only want to exchange $120, then it matters whether the shares are $80 or $40, but most of us trade in larger quantities of shares.

With respect to a Life Science Fund. Take a look at H& Q Life (HQL). It's down 50% and trading at a discount of 24%.

aj


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News